The effects of dihydralazine, labetalol and magnesium sulphate on the isolated, perfused human placental cotyledon

Objective To assess the effects of dihydralazine, labetalol and magnesium sulphate on the vascular tone in the isolated, perfused human placental cotyledon.

[1]  S. Chemtob,et al.  Responses of placental arteries from normotensive and preeclamptic women to endogenous vasoactive agents. , 1993, American journal of obstetrics and gynecology.

[2]  E. Reece,et al.  Effect of magnesium sulfate on plasma endothelin-1 levels in normal and preeclamptic pregnancies. , 1992, American journal of obstetrics and gynecology.

[3]  J. Rankin,et al.  Differential effects of intravenous hydralazine on myoendometrial and placental blood flow in hypertensive pregnant ewes. , 1992, American journal of obstetrics and gynecology.

[4]  B. Sibai,et al.  The case for magnesium sulfate in preeclampsia-eclampsia. , 1992, International journal of obstetric anesthesia.

[5]  K. Skajaa,et al.  Magnesium intake and status and pregnancy outcome in a Danish population , 1991, British journal of obstetrics and gynaecology.

[6]  A. Forman,et al.  Effects of Vasodilators on Isolated Human Uteroplacental Arteries , 1991, Obstetrics and gynecology.

[7]  A. Harper,et al.  Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol , 1991, British journal of obstetrics and gynaecology.

[8]  L. Myatt,et al.  The action of nitric oxide in the perfused human fetal-placental circulation. , 1991, American journal of obstetrics and gynecology.

[9]  D. Chestnut,et al.  Magnesium sulfate decreases maternal blood pressure but not uterine blood flow during epidural anesthesia in gravid ewes. , 1991, Anesthesiology.

[10]  D. Svane,et al.  Effects of magnesium and isradipine on contractile activation induced by the thromboxane A2 analog U46619 in human uteroplacental arteries in term pregnancy. , 1990, American journal of obstetrics and gynecology.

[11]  K. Andersson,et al.  Effects of magnesium on isolated human fetal and maternal uteroplacental vessels. , 1990, Acta physiologica Scandinavica.

[12]  B. Wílkes,et al.  Endothelin receptors in human placenta: relationship to vascular resistance and thromboxane release. , 1990, The American journal of physiology.

[13]  E. Liu,et al.  Evidence for functional thromboxane A2-prostaglandin H2 receptors in human placenta. , 1989, The American journal of physiology.

[14]  V. Parisi,et al.  Fetoplacental vascular responses to prostacyclin after thromboxane-induced vasoconstriction. , 1989, American journal of obstetrics and gynecology.

[15]  N. Lunell,et al.  Dihydralazine and the uteroplacental blood flow. , 1988, American journal of obstetrics and gynecology.

[16]  K. W. Elkington.  A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. , 1988, Obstetrics and gynecology.

[17]  E. Amon,et al.  A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy , 1987, Obstetrics and gynecology.

[18]  B. Sibai,et al.  A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term , 1987, Obstetrics and gynecology.

[19]  J. Nadler,et al.  Evidence that prostacyclin mediates the vascular action of magnesium in humans. , 1987, Hypertension.

[20]  R. Ahokas,et al.  The effect of hydralazine on placental perfusion in the spontaneously hypertensive rat. , 1987, American journal of obstetrics and gynecology.

[21]  S. Maigaard.  CONTRACTION AND RELAXATION OF HUMAN UTERINE AND PLACENTAL SMOOTH MUSCLE , 1987, Acta obstetricia et gynecologica Scandinavica. Supplement.

[22]  K. Andersson,et al.  Relaxant and contractile effects of some amines and prostanoids in myometrial and vascular smooth muscle within the human uteroplacental unit. , 1986, Acta physiologica Scandinavica.

[23]  B. Sibai,et al.  Fetal Distress After Hydralazine Therapy for Severe Pregnancy-Induced Hypertension , 1986, Southern medical journal.

[24]  O. Ylikorkala,et al.  Labetalol does not alter the placental and fetal blood flow or maternal prostanoids in pre‐eclampsia , 1986, British journal of obstetrics and gynaecology.

[25]  H. Jacob,et al.  Magnesium sulfate: rationale for its use in preeclampsia. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Thiagarajah,et al.  Magnesium sulfate and ritodrine hydrochloride: systemic and uterine hemodynamic effects. , 1985, American journal of obstetrics and gynecology.

[27]  O. Ylikorkala,et al.  Effects of Dihydralazine Infusion on the Fetoplacental Blood Flow and Maternal Prostanoids , 1985, Obstetrics and gynecology.

[28]  N. Lunell,et al.  Uteroplacental Blood Flow in Pregnancy Induced Hypertension , 1985, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[29]  L. Myatt,et al.  The effects of the components of the renin-angiotensin system on the isolated perfused human placental cotyledon. , 1984, American journal of obstetrics and gynecology.

[30]  W. Walters,et al.  Effects of vasoactive autacoids on the human umbilical‐fetal placental vasculature , 1984, British journal of obstetrics and gynaecology.

[31]  N. Lunell,et al.  Labetalol for the Treatment of Hypertension in Pregnancy: Pharmakokinetics and effects on the uteroplacental blood flow , 1984, Acta obstetricia et gynecologica Scandinavica. Supplement.

[32]  V. Kreye.  Direct vasodilators with unknown modes of action: the nitro-compounds and hydralazine. , 1984, Journal of cardiovascular pharmacology.

[33]  N. Vlachakis,et al.  Study of single and multiple dose pharmacokinetic/pharmacodynamic modeling of the antihypertensive effects of labetalol. , 1983, The American journal of medicine.

[34]  J. Mcgiff,et al.  Endothelial Mechanism in the Vascular Action of Hydralazine , 1983, Hypertension.

[35]  N. Lunell,et al.  Acute effect of dihydralazine on uteroplacental blood flow in hypertension during pregnancy. , 1983, Gynecologic and obstetric investigation.

[36]  S. Yeh,et al.  The effect of magnesium sulfate on fetal heart rate variability and uterine activity. , 1981, American journal of obstetrics and gynecology.

[37]  B. Sibal,et al.  Reassessment of Intravenous MgSO4 Therapy in Preeclampsia–Eclampsia , 1981, Obstetrics and gynecology.

[38]  A. Riley.  Clinical Pharmacology of Labetalol in Pregnancy , 1981, Journal of cardiovascular pharmacology.

[39]  R. H. Philpott,et al.  Effect of dihydralazine on the fetus in the treatment of maternal hypertension. , 1980, Obstetrics and gynecology.

[40]  T. Tulenko.  Regional sensitivity to vasoactive polypeptides in the human umbilicoplacental vasculature. , 1979, American journal of obstetrics and gynecology.

[41]  T. Bolton.  Mechanisms of action of transmitters and other substances on smooth muscle. , 1979, Physiological reviews.

[42]  J. Rankin,et al.  The regulation of the placental blood flows. , 1979, Journal of developmental physiology.

[43]  F. Reilly,et al.  Neurohistochemical evidence supporting an absence of adrenergic and cholinergic innervation in the human placenta and umbilical cord , 1977, The Anatomical record.

[44]  S Horiguchi,et al.  [Fetal distress]. , 1971, Sanfujinka no jissai. Practice of gynecology and obstetrics.